Biogen licenses a possible immune drug from OrbiMed-backed biotech
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Biogen Licenses Immune Drug from Vanqua Bio Biogen has licensed a preclinical immune drug from Vanqua Bio, a biotech company backed by OrbiMed, in a deal worth over $1 billion. The …
Federal Judge Pauses Order Disqualifying US Attorney for Nevada A federal judge has paused his order disqualifying the acting U.S. attorne…
Kerala High Court Upholds Devaswom Board's Power The Kerala High Court has upheld the Travancore Devaswom Board's authority to approve Tha…
Truck Driver in California Crash Charged with Manslaughter A truck driver, identified as 21-year-old Jashanpreet Singh, was charged with g…
Nothing Adds Bloatware to Phones for Revenue Nothing started rolling out the first Nothing OS 4.0 beta build to its Phone 3a series, but u…
Reforms to Strengthen Disability Rights in Ghana President John Dramani Mahama has announced a comprehensive set of reforms to modernize G…
The Purr-fect Halloween Cat Lulu, a domestic shorthair mix, is the perfect companion for the upcoming spooky season. She loves to c…
Nana Konadu's Legacy Deputy Presidential Spokesperson Shamima Muslim described the passing of former First Lady Nana Konadu Agyeman-Rawlin…
Mizzou Volleyball Secures Thrilling Victory Over LSU Mizzou volleyball delivered a 3-1 victory over Louisiana State University on Oct. 19,…
Lewis Capaldi Announces 2026 North American Tour Global superstar Lewis Capaldi is set to return to North America on a headlining tour, la…
Bombay HC Quashes Pension Forfeiture of Retired Excise Officer The Bombay High Court has quashed disciplinary proceedings and restored pen…